Method for directed intranasal administration of a composition
View Patent ↗Methods, kits, apparatus, and compositions for inhibiting a cerebral neurovascular disorder, a muscular headache, or cerebral inflammation in a human patient are provided. The methods comprise intranasally administering to the patient a pharmaceutical composition comprising a local anesthetic, and preferably a long-acting local anesthetic ingredient. A composition useful for practicing the methods of the invention is described which comprises at least one local anesthetic in a pharmaceutically acceptable carrier, wherein the composition is formulated for intranasal delivery. Cerebral neurovascular disorders include migraine and cluster headache. Muscular headaches include tension headaches and muscle contraction headaches. A kit comprising the composition and an intranasal applicator and a method of systemically delivering a pharmaceutically active agent to an animal are also included in the invention. Apparatus for directed intranasal administration of the compositions of the invention and for performing the methods of the invention are also described.
1. A method of inhibiting a cerebral neurovascular disorder associated with pain in a human patient, the method comprising implanting an electronic neural stimulator in patient tissue adjacent a dorsonasal nerve structure and energizing the implanted electronic neural stimulator, so as to inhibit pain.
2. The method of claim 1 wherein the dorsonasal nerve structure is an SPG or branch thereof.
3. The method of claim 1 further comprising providing power to the implanted electronic neural stimulator using an external power supply.
4. The method of claim 3 wherein the step of providing power comprises inductively coupling the external power supply to the electronic neural stimulator.
5. The method of claim 1 further comprising effecting nerve block of the dorsonasal nerve structure.
6. A method of inhibiting migraine or headache in a human patient, the method comprising implanting an electronic neural stimulator in patient tissue adjacent a dorsonasal nerve structure and energizing the implanted electronic neural stimulator to effect nerve block of the dorsonasal nerve structure, so as to inhibit the migraine or the headache.
7. The method of claim 6 wherein the dorsonasal nerve structure is an SPG or branch thereof.
8. The method of claim 6 further comprising providing power to the implanted electronic neural stimulator using an external power supply.
9. The method of claim 8 wherein the step of providing power comprises inductively coupling the external power supply to the electronic neural stimulator.